1.Current Situation and Consideration of Refinement of Hospital Team Service based on Value-based Medicine
Jun DUAN ; Li YI ; Hanjie CHEN ; Chang LIU ; Yuhan DIAO ; Haiyan LIU ; Guixiang HE ; Jing MEI ; Yan LIU ; Yun CHEN
Chinese Hospital Management 2024;44(2):63-66
Objective To describe and analyze the current situation of the four same type of departments in an hospital in order to provide a reference for the construction of"the most cost-effective medical care".Methods The CN-DRG were used to automatically group and compare the medical capacity and inpatient service efficiency of the hospital department groups,and in the refined analysis,one DRG disease group of in situ cancer and non-malignant disease loss uterine surgery and single species uterine fibroid was included,and the Kruskal-Wallis H test was used to further compare the differences in length of stay and various costs.Results It included a total of 22630 patients,whose weights varied from a maximum of 3948.62 in diagnostic group 1 to a minimum of 133.55 in diagnostic group 11.The cost consumption indexes ranged from a minimum of 0.89 in diagnostic group 5 to a maximum of 1.04 in diagnostic group 2,while the time consumption indexes ranged from a minimum of 0.48 in diagnostic group 11 to a maximum of 0.81 in diagnostic group 5.When comparing the diagnostic groups,there were statistically significant differences(P<0.05)in hospitalization days,total cost,diagnostic cost,therapeutic cost,and cost of supplies.Specifically,when comparing the diagnostic and treatment groups within departments,the differences in hospitalization days and all costs were statistically significant(P<0.05)in departments 1 and 2,the differences in diagnostic cost,therapeutic cost,and cost of supplies were statistically significant(P<0.05)in department 3.Conclusion There exists a notable disparity in the extent to which each diagnostic and treatment group contributes to the hospital's service capacity and cost variability.Consequently,it is necessary to reasonably evaluate the length of hospital stay and medical cost of patients to achieve the highest cost-effective medical treatment.
2.Dosimetric comparison between IMRT and VMAT in patients undergoing internal mammary lymph node radiotherapy after modified radical mastectomy
Jie YU ; Qing LI ; Daolin ZENG ; Hanjie YI ; Guangjin LIU ; Qiongyu LAN
Chinese Journal of Radiation Oncology 2020;29(11):978-981
Objective:To investigate the dosimetric differences in volumetric-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT) in patients receiving adjuvant radiotherapy and internal lymph node irradiation after left-sided modified radical mastectomy.Methods:VMAT and IMRT radiotherapy plans were established for 20 patients undergoing left-sided modified radical mastectomy. The dosimetric parameters of the target area and organs at risk were calculated by the dose volume histogram. The categorical variables were tested by χ2 or Fisher′ s exact probability test. The continuous variables with normal distribution were analyzed by paired-t test or rank-sum test. Results:Among the two radiotherapy techniques, the homogeneity index of IMRT was significantly higher than that of VMAT ( P<0.05). The time of VMAT treatment was significantly shorter than that of IMRT ( P<0.01). VMAT was superior to IMRT in V 20Gy and V 30Gy of the affected lung (both P<0.05). VMAT was superior to IMRT in the left anterior descending coronary artery D mean, D max, and heart V 30Gy, V 40Gy, D mean and D max(all P<0.01). The esophageal D mean in the VMAT group was superior to that in the IMRT group ( P<0.05). The V 5Gy and V 10Gy of the contralateral lung and the D max of the esophagus in the IMRT group were significantly better compared with those in the VMAT group (all P<0.05). Conclusions:VMAT can significantly reduce the dose of the heart, contralateral lung, spinal cord, esophagus and other vital organs, and shorten the treatment time. For patients who need adjuvant radiotherapy and internal mammary lymph node irradiation after left-sided modified radical mastectomy, VMAT technology can better protect normal tissues than IMRT.